References
- . Centers for Disease Control and Prevention; US Department of Health and Human Services. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf. 2011. Accessed February 7, 2012
- . World Health Organization. Diabetes action now booklet. http://www.who.int/diabetes/actionnow/booklet/en/. Accessed July 6, 2012
- . The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986
- . Stratton IM, Adler AI, Neil HA . Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–412
- . Cagliero E, Levina EV, Nathan DM. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care. 1999;22(11):1785–1789
- . Thaler LM, Ziemer DC, Gallina DL, . Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making. Diabetes Care. 1999;22(9):1415–1421
- . Ferenczi A, Reddy K, Lorber DL. Effect of immediate hemoglobin A1c results on treatment decisions in office practice. Endocr Pract. 2001;7(2):85–88
- . UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853
- . Khaw KT, Wareham N, Luben R, . Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ. 2001;322(7277):15–18
- . American Diabetes Association. Standards of medical care in diabetes—2011. Diabetes Care. 2011;34( suppl 1):S11–S61
- . Handelsman Y, Mechanick JI, Blonde L, ; AACE Task Force for Developing Diabetes Comprehensive Care Plan. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011;17( suppl 2):1–53
- . Price CA, St John A. Point-of-Care Testing for Managers and Policymakers: From Rapid Testing to Better Outcomes. Washington, DC: AAAC Press; 2010
- . Grant R, Adams AS, Trinacty CM, . Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care. 2007;30(4):807–812
- . Hood KK, Peterson CM, Rohan JM, Drotar D. Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis. Pediatrics. 2009;124(6):e1171–e1179
- . St John A, Boyd JC, Lowes AJ, Price CP. The use of urinary dipstick tests to exclude urinary tract infection: a systematic review of the literature. Am J Clin Pathol. 2006;126(3):428–436
- . Grabe M, Bishop MC, Bjerklund-Johansen TE, . Guidelines on Urological Infections. Arnhem, The Netherlands: European Association of Urology (EAU); 2009
- . Despotis GJ, Joist JH, Goodnough LT. Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. Clin Chem. 1997;43(9):1684–1696
- . Chen H, Sokoll LJ, Udelsman R. Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay. Surgery. 1999;126(6):1016–1021
- . Bruns DE, Boyd JC. Few point-of-care hemoglobin A1c assay methods meet clinical needs. Clin Chem. 2010;56(1):4–6
- . Lenters-Westra E, Slingerland RJ. Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria. Clin Chem. 2010;56(1):44–52
- . Lenters-Westra E, Slingerland RJ. Hemoglobin A1c point-of-care assays; a new world with a lot of consequences! J Diabetes Sci Technol. 2009;3(3):418–423
- . National Glycohemoglobin Standardization Program. International Federation of Clinical Chemistry (IFCC) standardization of HbA1c. http://www.ngsp.org/ifcc.asp. Accessed July 6, 2012
- . National Glycohemoglobin Standardization Program. 2009 NGSP Steering Committee meeting. http://www.ngsp.org/SC2009.asp. Accessed July 29, 2010
- . National Glycohemoglobin Standardization Program. New NGSP certification criteria beginning in September, http://www.ngsp.org/news.asp. Updated July 24, 2012. Accessed July 25, 2012
- . US Food and Drug Administration. Clinical Laboratory Improvement Amendments (CLIA) waivers. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/IVDRegulatoryAssistance/ucml24202.htm. Accessed July 6, 2012
- . Bode BW, Irvin BR, Pierce JA, Allen M, Clark AL. Advances in hemoglobin A1c point of care technology. J Diabetes Sci Technol. 2007;1(3):405–411
- . National Glycohemoglobin Standardization Program. HbA1c assay interferences. http://www.ngsp.org/interf.asp. Accessed July 6, 2012
- . International Diabetes Federation. Global guideline for type 2 diabetes. http://www.idf.org/webdata/docs/IDF%20GGT2D.pdf. Accessed October 12, 2005
- . College of American Pathologists. CAP GH2 survey data. http://www.ngsp.org/CAPdata.asp. Accessed July 6, 2012